Mar­i­nus plans an­oth­er round of lay­offs, cost cuts fol­low­ing Phase 3 fail

Mar­i­nus Phar­ma­ceu­ti­cals is re­duc­ing its work­force again and tak­ing oth­er mea­sures to re­duce costs af­ter its epilep­sy treat­ment failed a late-stage tri­al.

The TrustTSC tri­al …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER